Literature DB >> 25762085

Endograft infection after hybrid surgery for chronic Stanford type B aortic dissection: endograft infection and treatment.

Manabu Yamasaki1, Kohei Abe2, Hiroyasu Misumi2, Joji Ito2, Yusuke Nakanishi2, Kohei Kawazoe2.   

Abstract

While the incidence of endograft infection is very low, the treatment is difficult when it occurs. We herein present the case of a 52-year-old male who had undergone a graft replacement in the proximal descending thoracic aorta for dissected aortic aneurysm (DA) 6 years previously and hybrid surgery 2 years previously, which consisted of an abdominal graft replacement, visceral and renal debranching surgery and endovascular surgery for a ruptured abdominal DA and residual thoracoabdominal DA. Following collapse from septic shock due to an endograft infection, we performed an in situ reconstruction of the entire thoracoabdominal aorta following intensive antibiotic therapy and 2 preoperative CT-guided percutaneous interventions. He was discharged 4 weeks after the surgery without any complications.

Entities:  

Keywords:  Aortic operation (operation on the aorta); Endovascular procedures/stents; PCI

Mesh:

Year:  2015        PMID: 25762085     DOI: 10.1007/s00595-015-1148-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

Review 1.  The current role of rifampicin-impregnated grafts: pragmatism versus science.

Authors:  J J Earnshaw
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

Review 2.  Current role of imaging in diagnosing aortic graft infections.

Authors:  Janneke L M Bruggink; Riemer H J A Slart; Jillis A Pol; Michel M P J Reijnen; Clark J Zeebregts
Journal:  Semin Vasc Surg       Date:  2011-12       Impact factor: 1.000

Review 3.  A systematic review and meta-analysis of treatments for aortic graft infection.

Authors:  Stephen O'Connor; Peter Andrew; Michel Batt; Jean Pierre Becquemin
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

Review 4.  Management of endograft infections.

Authors:  F Numan; F Gulsen; S Solak; M Cantasdemir
Journal:  J Cardiovasc Surg (Torino)       Date:  2011-04       Impact factor: 1.888

5.  The relevance of aortic endograft prosthetic infection.

Authors:  Paul Cernohorsky; Michel M P J Reijnen; Ignace F J Tielliu; Steven M M van Sterkenburg; Jan J A M van den Dungen; Clark J Zeebregts
Journal:  J Vasc Surg       Date:  2011-03-11       Impact factor: 4.268

Review 6.  Management of thoracic endograft infection.

Authors:  R Chiesa; Y Tshomba; A Kahlberg; E M Marone; E Civilini; G Coppi; D Psacharopulo; G Melissano
Journal:  J Cardiovasc Surg (Torino)       Date:  2010-02       Impact factor: 1.888

7.  Periaortic endograft infection due to Listeria monocytogenes treated with graft preservation.

Authors:  Ben R Saleem; Paul Berger; Clark J Zeebregts; Riemer H Slart; Eric L Verhoeven; Jan J van den Dungen
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

8.  Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed Dacron graft.

Authors:  K Lachapelle; A M Graham; J F Symes
Journal:  J Vasc Surg       Date:  1994-04       Impact factor: 4.268

9.  Treatment strategies for aortic and peripheral prosthetic graft infection.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Surg Today       Date:  2013-04-05       Impact factor: 2.549

10.  The in vitro research of bacterial invasion of prosthetic vascular grafts: comparison of elastomer-sealed and gelatin-coated Dacron vascular grafts.

Authors:  Yuki Sasaki
Journal:  Surg Today       Date:  2013-10-20       Impact factor: 2.549

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.